Annual CFI
-$69.74 M
-$4.17 M-6.36%
December 31, 2024
Summary
- As of March 15, 2025, CTNM annual cash flow from investing activities is -$69.74 million, with the most recent change of -$4.17 million (-6.36%) on December 31, 2024.
- During the last 3 years, CTNM annual CFI has fallen by -$4.77 million (-7.34%).
- CTNM annual CFI is now -412.74% below its all-time high of $22.30 million, reached on December 31, 2022.
Performance
CTNM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$9.39 M
+$20.80 M+68.90%
December 31, 2024
Summary
- As of March 15, 2025, CTNM quarterly cash flow from investing activities is -$9.39 million, with the most recent change of +$20.80 million (+68.90%) on December 31, 2024.
- Over the past year, CTNM quarterly CFI has increased by +$20.80 million (+68.90%).
- CTNM quarterly CFI is now -200.35% below its all-time high of $9.36 million, reached on March 1, 2023.
Performance
CTNM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$69.74 M
-$18.42 M-35.89%
December 31, 2024
Summary
- As of March 15, 2025, CTNM TTM cash flow from investing activities is -$69.74 million, with the most recent change of -$18.42 million (-35.89%) on December 31, 2024.
- Over the past year, CTNM TTM CFI has dropped by -$18.42 million (-35.89%).
- CTNM TTM CFI is now -845.47% below its all-time high of $9.36 million, reached on March 1, 2023.
Performance
CTNM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CTNM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.4% | +68.9% | -35.9% |
| 3 y3 years | -7.3% | - | - |
| 5 y5 years | -7.3% | - | - |
CTNM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -412.7% | at low | -200.3% | +78.9% | -845.5% | +6.5% |
| 5 y | 5-year | -412.7% | at low | -200.3% | +78.9% | -845.5% | +6.5% |
| alltime | all time | -412.7% | at low | -200.3% | +78.9% | -845.5% | +6.5% |
Contineum Therapeutics Class A Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$69.74 M(+6.4%) | -$9.39 M(-68.9%) | -$69.74 M(+35.9%) |
| Sep 2024 | - | -$30.18 M(-22.4%) | -$51.32 M(-15.4%) |
| Jun 2024 | - | -$38.90 M(-545.5%) | -$60.63 M(-8.4%) |
| Mar 2024 | - | $8.73 M(-3.3%) | -$66.19 M(+1.0%) |
| Dec 2023 | -$65.57 M | $9.03 M(-122.9%) | -$65.57 M(-12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$39.50 M(-11.2%) | -$74.60 M(+112.5%) |
| Jun 2023 | - | -$44.46 M(-575.2%) | -$35.10 M(-475.2%) |
| Mar 2023 | - | $9.36 M | $9.36 M |
| Dec 2022 | $22.30 M(-134.3%) | - | - |
| Dec 2021 | -$64.97 M | - | - |
FAQ
- What is Contineum Therapeutics Class A annual cash flow from investing activities?
- What is the all time high annual CFI for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual CFI year-on-year change?
- What is Contineum Therapeutics Class A quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly CFI year-on-year change?
- What is Contineum Therapeutics Class A TTM cash flow from investing activities?
- What is the all time high TTM CFI for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A TTM CFI year-on-year change?
What is Contineum Therapeutics Class A annual cash flow from investing activities?
The current annual CFI of CTNM is -$69.74 M
What is the all time high annual CFI for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual cash flow from investing activities is $22.30 M
What is Contineum Therapeutics Class A annual CFI year-on-year change?
Over the past year, CTNM annual cash flow from investing activities has changed by -$4.17 M (-6.36%)
What is Contineum Therapeutics Class A quarterly cash flow from investing activities?
The current quarterly CFI of CTNM is -$9.39 M
What is the all time high quarterly CFI for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly cash flow from investing activities is $9.36 M
What is Contineum Therapeutics Class A quarterly CFI year-on-year change?
Over the past year, CTNM quarterly cash flow from investing activities has changed by +$20.80 M (+68.90%)
What is Contineum Therapeutics Class A TTM cash flow from investing activities?
The current TTM CFI of CTNM is -$69.74 M
What is the all time high TTM CFI for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high TTM cash flow from investing activities is $9.36 M
What is Contineum Therapeutics Class A TTM CFI year-on-year change?
Over the past year, CTNM TTM cash flow from investing activities has changed by -$18.42 M (-35.89%)